What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.11%Below 5Y avg (6.97%)
Annual Rate
CNY 0.12Paid annual
Payout Ratio
1650.0%High
Payback Period
47.1 yr
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
What stands out
Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
12.14BCNY
1.81B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
353.48BCNY
52.57B · vs all stocks (USD)
Updated Aug 20, 2026
Beta
0.4400x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-10.55%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
12.14BCNY
1.81B · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
36.59BCNY
5.44B · vs all stocks (USD)
Updated Aug 20, 2026
Forward P/E
5.80x
vs Conglomerates peers
Updated Aug 20, 2026
Price to Sales (TTM)
0.0343x
vs Conglomerates peers
Updated Aug 20, 2026
Price to Book (MRQ)
0.6294x
vs Conglomerates peers
Updated Aug 20, 2026
Enterprise to Revenue
0.1040x
vs Conglomerates peers
Updated Aug 20, 2026
Enterprise to EBITDA
13.18x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 10.56×.Updated Aug 20, 2026
Gross Margin
3.82%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 1.61%.Updated Aug 20, 2026
Operating Margin
3.04%
vs Conglomerates peers
Updated Aug 20, 2026
Return on Assets (TTM)
0.98%
vs Conglomerates peers
Updated Aug 20, 2026
Return on Equity (TTM)
-0.06%
vs Conglomerates peers
Updated Aug 20, 2026
Revenue (TTM)
353.48BCNY
52.57B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
166.59CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
23.20%
vs Conglomerates peers
Updated Aug 20, 2026
Gross Profit (TTM)
5.69BCNY
845.47M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
3.47BCNY
515.46M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-226.99MCNY
-33.76M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-39.70%
vs Conglomerates peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
-31.17BCNY
-4.63B · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
-10.43BCNY
-1.55B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing Annual Dividend Rate
0.1200CNYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
2.11%
vs all stocks
Updated Aug 20, 2026
5-Year Average Dividend Yield
6.97%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
1650.00%
vs Conglomerates peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -300%.Updated Aug 20, 2026
Minority Interest (Equity)
3.51BCNYFY2025 · Dec 31, 2025
Revenue
337.12BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
331.99BCNYFY2025 · Dec 31, 2025
Gross Profit
5.13BCNYFY2025 · Dec 31, 2025
Operating Income
2.48BCNY
369.51M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
414.77MCNYFY2025 · Dec 31, 2025
Income Tax Expense
272.98MCNYFY2025 · Dec 31, 2025
Net Income
141.78MCNYFY2025 · Dec 31, 2025
EBIT
1.26BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
3.96BCNYFY2025 · Dec 31, 2025
Research & Development
87.10MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
713.24MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
456.49MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
271.22MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
841.25MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0200CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0200CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
25.45BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
25.45BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
141.78MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
367.27MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-10.79BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-12.26BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
6.72BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
141.78MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.02BCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-3.19BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-8.76BCNYFY2025 · Dec 31, 2025
Capital Expenditures
1.47BCNYFY2025 · Dec 31, 2025
Net Acquisitions
20.81MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-27.23BCNYFY2025 · Dec 31, 2025
Sale of Investments
30.26BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-3.77MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
4.52BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
115.07BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-118.07BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.90BCNYFY2025 · Dec 31, 2025
Other Financing Charges
-789.56MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-5.69BCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.14BSharesUpdated Aug 20, 2026
Float Shares
1.30BSharesUpdated Aug 20, 2026
% Held by Insiders
38.84%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
8.00%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
26.31BCNY
3.91B · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
12.31CNYUpdated Aug 20, 2026
Total Debt (MRQ)
47.46BCNY
7.06B · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
1.25x
vs Conglomerates peers
Updated Aug 20, 2026
Current Ratio (MRQ)
1.13x
vs Conglomerates peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
9.03CNYUpdated Aug 20, 2026
Total Assets
105.35BCNY
15.67B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
81.71BCNYFY2025 · Dec 31, 2025
Total Liabilities
68.72BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
23.64BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
3.84BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
64.88BCNYFY2025 · Dec 31, 2025
Cash
3.02BCNYFY2025 · Dec 31, 2025
Cash Equivalents
4.21BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
7.23BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
2.19BCNYFY2025 · Dec 31, 2025
Accounts Receivable
11.82BCNYFY2025 · Dec 31, 2025
Inventory
31.79BCNYFY2025 · Dec 31, 2025
Accounts Payable
34.71BCNYFY2025 · Dec 31, 2025
Short-term Debt
9.89BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
4.41BCNYFY2025 · Dec 31, 2025
Long-term Debt
3.66BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
5.73MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.14BCNYFY2025 · Dec 31, 2025
Retained Earnings
11.68BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
36.63BCNY
5.45B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
26.88MCNYFY2025 · Dec 31, 2025
52-Week Low
5.37CNYUpdated Aug 20, 2026
52-Week High
8.72CNYUpdated Aug 20, 2026
52-Week Change
-10.55%
vs all stocks
Updated Aug 20, 2026
Beta
0.4400x
vs all stocks
Updated Aug 20, 2026
50-Day MA
5.72CNYUpdated Aug 20, 2026
200-Day MA
6.35CNYUpdated Aug 20, 2026
Avg 10-Day Volume
10.72MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
15.35MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-0.0400CNYUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.23Receivables vs revenue divergence: 2.06
Financial Health
Altman Z-Score 3.69: safe zoneNotable
Altman Z-Score: 3.69
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Revenue is $52.57B, higher than 95% of all stocks globallySignificant